Medical Imaging Disruptor Nano-X Pushes On With Launch Plans In Face Of Shareholder Lawsuit
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.
You may also be interested in...
SUMMIT, the landmark study conducted within the UK focused on diagnosing lung cancer before it becomes untreatable, has demonstrated the practicality and cost effectiveness of mass CT screening.
During Q4, device company fundraising totaled $4.2bn; while in vitro diagnostic firms and research tools players raised $6.1bn.
Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.